Reliance Life gets regulatory approval for the phase-1 trial of its proposed two-dose covid-19 vaccine
The subject expert committee reviewed the application
And, the Drug Regulatory Authority gave the approval on Thursday
Reliance Life had approached the drug regulator for the approval of its recombinant protein-based vaccine
